Fig. 1From: Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysisCONSORT (the Consolidated Standards of Reporting Trials) diagramBack to article page